臧利

[摘要] 目的 分析依达拉奉联合银杏达莫治疗2型糖尿病并发急性脑梗塞临床效果。方法 选取132例2型糖尿病并发急性脑梗塞患者，于2018年1月—2019年9月入院，随机分为观察组（依达拉奉联合银杏达莫治疗）与对照组（银杏达莫治疗），每组66例。比较两组临床疗效及治疗前、后的神经功能缺损评分、椎基底动脉血流速。 结果 观察组临床疗效（96.96%）高于对照组（84.84%）（P<0.05），经治疗后，观察组神经功能缺损评分低于对照组，且观察组椎基底动脉血流速均优于对照组，差异有统计学意义（P<0.05）。 结论 在常规治疗的基础上应用依达拉奉联合银杏达莫治疗，可显著改善患者神经功能缺损情况，提高椎基底动脉血流速度，临床治疗效果显著。

[关键词] 依达拉奉;银杏达莫;2型糖尿病并发急性脑梗塞;临床效果

[中图分类号] R4          [文献标识码] A          [文章编号] 1672-4062（2020）05（b）-0072-03

Clinical Analysis of Edaravone Combined with Ginkgo Leaf Extract and Diphyridamole Injection in Treatment of Type 2 Diabetes with Acute Cerebral Infarction

ZANG Li

Department of Internal Medicine， Tieren Hospital of Daqing Oilfield， Daqing， Heilongjiang Province， 163413 China

[Abstract] Objective To analyze the clinical effect of edaravone combined with ginkgo damo in treating type 2 diabetes with acute cerebral infarction. Methods A total of 132 patients with type 2 diabetes complicated by acute cerebral infarction were selected and admitted to hospital between January 2018 and September 2019. They were randomly divided into observation group （edaravone combined with Ginkgo Leaf Extract and Diphyridamole Injection） and control group （treated with Ginkgo Leaf Extract and Diphyridamole Injection）， 66 cases in each group. The clinical efficacy， neurological deficit score， and vertebrobasilar blood flow rate before and after treatment were compared between the two groups. Results The clinical efficacy of the observation group （96.96%） was higher than that of the control group （84.84%） （P<0.05）. After treatment， the neurological deficit score of the observation group was lower than that of the control group， and the vertebrobasilar blood flow rate in the observation group was more excellent than the control group， the difference was statistically significant （P<0.05）. Conclusion The application of edaravone combined with Ginkgo Leaf Extract and Diphyridamole Injection on the basis of conventional treatment can significantly improve the neurological deficits and increase the blood flow velocity of the vertebrobasilar artery. The clinical treatment effect is significant.

[Key words] Edaravone; Ginkgo Leaf Extract and Diphyridamole Injection; Type 2 diabetes complicated by acute cerebral infarction; Clinical effect

2型糖尿病又叫做成人發病型糖尿病，是临床常见病症，且我国目前病症病发率呈上升趋势，多病发于老年人之中，严重影响其机体健康及生活质量，而且糖尿病是会造成患者出现胰岛素分泌障碍的病症，从而导致患者血液浓稠度增高，加之老年患者病发率比例较高，有着较高的病发脑梗死几率，严重威胁患者的生命健康[1]。目前临床常见治疗方式，以药物治疗为主，但其效果不佳，仍存在较高的致残率及致死率，是长期以来医学界的最大困扰问题之一。有相关数据表明，药物的联合治疗可有效改善患者病情，银杏达莫是治疗脑血管、心血管疾病的常用药物，而依达拉奉是一种新型自由基清除剂，可有效改善患者病情，该文于2018年1月—2019年9月以2型糖尿病病发急性脑梗塞患者132例为探究对象，分析采用依达拉奉联合银杏达莫药物治疗效果，现报道如下。

1  资料与方法

1.1  一般资料

选取该院收治的2型糖尿病并发急性脑梗塞患者132例，采用治疗方式不同分为观察组（依达拉奉联合银杏达莫治疗）与对照组（常规治疗），每组66例。……